Your shopping cart is currently empty

GK730 is a potent and selective inhibitor of the SARS-CoV-2 main protease, with an IC50 value of 5.75 nM. It does not inhibit cathepsin B and shows weak inhibition of cathepsin L (IC50 of 11 μM). GK730 effectively blocks both viral replication and the entry pathways of variants like Omicron. In Vero E6 cells, the EC50 value for wild-type SARS-CoV-2 is 5.70 μM, with a CC50 value greater than 100 μM. GK730 is applicable for COVID-19 research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | GK730 is a potent and selective inhibitor of the SARS-CoV-2 main protease, with an IC50 value of 5.75 nM. It does not inhibit cathepsin B and shows weak inhibition of cathepsin L (IC50 of 11 μM). GK730 effectively blocks both viral replication and the entry pathways of variants like Omicron. In Vero E6 cells, the EC50 value for wild-type SARS-CoV-2 is 5.70 μM, with a CC50 value greater than 100 μM. GK730 is applicable for COVID-19 research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.